Cite

HARVARD Citation

    Sever, P. et al. (2021). LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial. European journal of preventive cardiology. pp. 805-812. [Online]. 
  
Back to record